Raia Drogasil S.A. (OTCMKTS:RADLY – Get Free Report)’s stock price hit a new 52-week low during trading on Thursday. The stock traded as low as $2.61 and last traded at $2.62, with a volume of 7,081 shares trading hands. The stock had previously closed at $2.68.
Analysts Set New Price Targets
Separately, Jefferies Financial Group upgraded shares of Raia Drogasil to a “buy” rating and set a $5.20 target price for the company in a report on Sunday, October 18th. One equities research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $5.20.
Read Our Latest Analysis on Raia Drogasil
Raia Drogasil Trading Down 2.1%
The company has a quick ratio of 0.58, a current ratio of 1.41 and a debt-to-equity ratio of 0.99. The firm has a market cap of $3.45 billion and a P/E ratio of 17.47. The firm’s fifty day moving average is $3.60 and its two-hundred day moving average is $4.01.
Raia Drogasil (OTCMKTS:RADLY – Get Free Report) last announced its earnings results on Tuesday, November 3rd. The company reported $0.05 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.05. The firm had revenue of $2.22 billion for the quarter, compared to analyst estimates of $2.43 billion. Raia Drogasil had a net margin of 2.89% and a return on equity of 20.61%. Analysts predict that Raia Drogasil S.A. will post 0.17 earnings per share for the current fiscal year.
Raia Drogasil Company Profile
Raia Drogasil, now known as RD Saúde, is a Brazilian health and pharmacy retail company formed in 2011 through the merger of Droga Raia and Drogasil. It operates pharmacy stores under the Raia and Drogasil brands. The company sells prescription and over-the-counter medicines, personal care and beauty products, and other health and wellness goods. It serves customers across Brazil through its retail locations and digital channels, including online ordering and delivery. In addition to pharmacy retail, RD Saúde provides health-related services through its stores and digital platforms.
Further Reading
- Five stocks we like better than Raia Drogasil
- Midterm Fallout, NVIDIA Turmoil, Anthropic’s IPO: Is Broadcom a Steal?
- 3 Pharmaceutical Stocks That Offer Safety and Growth
- If Japan’s Stock Market Rally Returns, These 3 ETFs Could Benefit
- CoreWeave’s Backlog Is Surging—Can the Stock Follow?
Receive News & Ratings for Raia Drogasil Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Raia Drogasil and related companies with MarketBeat.com's FREE daily email newsletter.
